Physician

Mhd Iyad Alshwaf, MD

According to 2025 Medicare claims, Mhd Alshwaf, MD (NPI: 1801399365) practices rheumatology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is JOSHUA P JUNE DO (NPI: 1548717580; TIN: 813717934) and primary practice location at 48911-4285. Alshwaf is affiliated with the POM ACO (ACO ID: A1297) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Alshwaf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 575 traditional Medicare patients, billed 108,151 HCPCS/CPT codes, and received $1,406,933 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,013 prescription claims across 357 beneficiaries totaling $1,967,420 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 213 records totaling $3,823. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $236,956 to $1,406,933. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $421,424 to $1,967,420. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$728K$1.5M2020 Medicare payment: $236,956 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $878,657 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,302,544 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,456,968 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,406,933 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202033211,326$236,956
202155939,730$878,657
202248469,318$1,302,544
2023604109,821$1,456,968
2024575108,151$1,406,933

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2018 Drug cost: $421,424 (USD; Tot_Drug_Cst)2019 Drug cost: $1,021,258 (USD; Tot_Drug_Cst)2020 Drug cost: $788,087 (USD; Tot_Drug_Cst)2021 Drug cost: $1,182,923 (USD; Tot_Drug_Cst)2022 Drug cost: $1,209,595 (USD; Tot_Drug_Cst)2023 Drug cost: $2,022,934 (USD; Tot_Drug_Cst)2024 Drug cost: $1,967,420 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018223864$421,424
20192981,673$1,021,258
20202991,193$788,087
20214131,791$1,182,923
20223631,789$1,209,595
20233522,180$2,022,934
20243572,013$1,967,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more437832$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more251485$63
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less85289$43
J0897Injection, denosumab, 1 mg896,840$21
96372Injection of drug or substance under skin or into muscle162349$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept501,400$356,538
Humira(Cf) PenAdalimumab361,064$256,816
Orencia ClickjectAbatacept381,064$216,249
TeriparatideTeriparatide601,682$184,596
Cosentyx Sensoready (2 Pens)Secukinumab23660$172,132

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.213$3,823Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mhd Iyad Alshwaf, MD?

Tedicare shows public-source Medicare data for Mhd Iyad Alshwaf, MD (NPI 1801399365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mhd Iyad Alshwaf, MD have ACO affiliation data?

Mhd Iyad Alshwaf, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Mhd Iyad Alshwaf, MD?

Mhd Iyad Alshwaf, MD is linked to JOSHUA P JUNE DO (billing NPI 1548717580) in the available physician profile data.

Does Mhd Iyad Alshwaf, MD have Open Payments data?

Mhd Iyad Alshwaf, MD has 213 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.